Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Mar 27, 2023; 15(3): 362-373
Published online Mar 27, 2023. doi: 10.4240/wjgs.v15.i3.362
Published online Mar 27, 2023. doi: 10.4240/wjgs.v15.i3.362
Variable | n (%) or mean (95%CI) | P value1 | |||
ERAS < 50 (n = 102) | ERAS ≥ 50 (n = 14) | ||||
Overall morbidity | 51 | 50.0% | 4 | 28.6% | 0.132 |
Hepatobiliary complications | 0.281 | ||||
Post-hepatectomy liver failure | 14 | 13.7% | 0 | 0% | |
Bile leakage | 4 | 3.9% | 0 | 0% | |
Stricture/cholangitis | 1 | 0.9% | 0 | 0% | |
Transient hyperbilirubinemia | 9 | 8.8% | 0 | 0% | |
General complications | |||||
Wound complications | 18 | 18.8% | 0 | 0% | 0.076 |
Pulmonary complications | 9 | 8.8% | 2 | 14.3% | 0.513 |
Cardiac complication | 5 | 4.9% | 0 | 0% | 0.397 |
Acute kidney injury | 2 | 1.9% | 0 | 0 | 0.597 |
Post-operative stay (d) | 13.7 | 12.2-15.2 | 8.9 | 7.3-10.4 | 0.022 |
Cholesterol | |||||
Postoperative day 1 | 131.5 | 123.9-138.9 | 151.1 | 141.2-160.9 | 0.057 |
Postoperative day 3 | 107.3 | 101.5-113.1 | 127.7 | 116.7-138.7 | 0.013 |
Postoperative day 5 | 96.6 | 90.8-102.5 | 118.1 | 109.1-127.2 | 0.009 |
Serum albumin | |||||
Postoperative day 1 | 3.0 | 2.9-3.1 | 3.1 | 2.9-3.3 | 0.271 |
Postoperative day 3 | 2.9 | 2.8-2.9 | 3.0 | 2.9-3.2 | 0.224 |
Postoperative day 5 | 2.8 | 2.7-2.9 | 2.9 | 2.8-3.1 | 0.425 |
Total bilirubin | |||||
Postoperative day 1 | 3.2 | 2.4-3.9 | 1.6 | 1.1-2.2 | 0.142 |
Postoperative day 3 | 2.7 | 2.1-3.4 | 1.4 | 0.9-2.0 | 0.171 |
Postoperative day 5 | 2.8 | 2.0-3.5 | 1.3 | 0.9-1.6 | 0.157 |
Alanine aminotransferase | |||||
Postoperative day 1 | 294.9 | 242.6-347.2 | 231.1 | 166.9-295.3 | 0.376 |
Postoperative day 3 | 169.4 | 142.6-196.3 | 177.6 | 124.1-231.1 | 0.829 |
Postoperative day 5 | 89.7 | 74.5-104.9 | 97.1 | 72.5-121.8 | 0.726 |
Aspartate aminotransferase | |||||
Postoperative day 1 | 386.5 | 323.4-449.7 | 285.2 | 196.4-373.9 | 0.247 |
Postoperative day 3 | 169.4 | 142.6-196.3 | 177.6 | 124.1-231.1 | 0.829 |
Postoperative day 5 | 89.7 | 74.5-104.9 | 97.1 | 72.5-121.8 | 0.726 |
International normalized ratio (PT/INR) | |||||
Postoperative day 1 | 1.27 | 1.2-1.35 | 1.27 | 1.18-1.35 | 0.939 |
Postoperative day 3 | 1.42 | 1.37-1.47 | 1.34 | 1.24-1.45 | 0.293 |
Postoperative day 5 | 1.39 | 1.3-1.49 | 1.26 | 1.17 -1.35 | 0.295 |
Postoperative mortality | |||||
30 d | 0 | 0% | 0 | 0% | |
60 d | 3 | 2.9% | 0 | 0% | |
Survival (95%CI) | 0.019 | ||||
Median (d) | 1257 | 853.2-1660.8 | Not reached | ||
1-yr survival | 77.5% | 63.1-89.1 | 100% | ||
3-yr survival | 50.9% | 37.1-67.9 | 85.7 | 53.9-96.2 |
- Citation: Jongkatkorn C, Luvira V, Suwanprinya C, Piampatipan K, Leeratanakachorn N, Tipwaratorn T, Titapun A, Srisuk T, Theeragul S, Jarearnrat A, Thanasukarn V, Pugkhem A, Khuntikeo N, Pairojkul C, Kamsa-Ard S, Bhudhisawasdi V. Compliance with enhanced recovery after surgery predicts long-term outcome after hepatectomy for cholangiocarcinoma. World J Gastrointest Surg 2023; 15(3): 362-373
- URL: https://www.wjgnet.com/1948-9366/full/v15/i3/362.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i3.362